1.Determination of residual epoxyethane in medical instruments by headspace capillary gas chromatography.
Dan LI ; Zhen-yuan WANG ; Shun-ning XIA
Chinese Journal of Medical Instrumentation 2007;31(3):201-230
OBJECTIVETo establish a method of determining the residual epoxyethane in medical instruments.
METHODAn HP-5 capillary column (30 m x 0.32 mm x 0.25 microm), an FID detecter and an oven were used in the determination. The oven temperature was kept at 120 degrees C for 8 minutes, the example inlet temperature was kept at 200 degrees C, while the detecter temperature was kept at 250 degrees C.
RESULTThe method has a linear range between 5.1920-51.920 microg, (r = 0.997, n = 6). The average rate of recovery of the injecter is 103.3%. The average rate of recovery of the infusion devices is 81.04%.
CONCLUSIONThe method has been proved to be convenient, sensitive and accurate. It is suitable for the determination of residual organic solvents in medical instruments.
Chromatography, Gas ; methods ; Disposable Equipment ; Epoxy Compounds ; analysis ; Ethane ; analysis ; Solvents ; analysis
2.Study on influence of processing methods on chemical constituents in Radix Paeoniae Alba.
Qiao WANG ; Rong-Xia LIU ; Hong-Zhu GUO ; Zhong-Ning ZHU ; Kai-Shun BI ; De-An GUO
China Journal of Chinese Materia Medica 2006;31(17):1418-1421
OBJECTIVEThe influence of processing methods on chemical constituents in Radix Paeoniae Alba was observed.
METHODA HPLC method was used for analyzing the changes of eight major constituents, namely gallic acid, paeoniflorin sulfonate, catechin, paeoniflorin sulfonate, albiflorin, paeoniflorin, benzoic acid, pentagalloylglucose and benzoylpaeoniflorin, with the three processing procedures of decorticating, boiling and fumigating by burning of sulphur. Analysis was performed using a Zorbax SB-C18 column (4.6 mm x 250 mm, 5 microm) with the mixture of acetonitrile (A) and 0.015% phosphoric acid solution as mobile phase in gradient mode. The detection wavelength was set at 230 nm and the column temperature was at 30 degrees C.
RESULTExcept for gallic acid and pentagalloylglucose, the other constituents decreased during procedure of decorticating and boiling. Fumigating by burning of sulphur would produce a new compound, paeoniflorin sulfonate, which was a byproduct from the reaction of paeoniflorin with SO2.
CONCLUSIONThe significant changes were produced in chemical constituents of Radix Paeoniae Alba during three processing procedures. Therefore, the processing of Radix Paeoniae Alba should be strictly controlled and standardized.
Benzoates ; analysis ; chemistry ; Bridged-Ring Compounds ; analysis ; chemistry ; Chromatography, High Pressure Liquid ; Gallic Acid ; analysis ; Glucosides ; analysis ; chemistry ; Hot Temperature ; Hydrolyzable Tannins ; analysis ; Molecular Structure ; Monoterpenes ; Paeonia ; chemistry ; Plant Roots ; chemistry ; Plants, Medicinal ; chemistry ; Sulfur ; Technology, Pharmaceutical ; methods
3.The molecular differences between genotype 1 and genotype 4 of HEV in their neutralization region.
Qing-Shun GUO ; Sheng-Xiang GE ; Jun-Hui XIONG ; Qiang YAN ; Shao-Wei LI ; Ying GU ; Ping-Dong XU ; Wei-Guo SHI ; Jun ZHANG ; Ning-Shao XIA
Chinese Journal of Virology 2007;23(6):454-458
HEV is classified into H (human) group and Z (zoonosis) group according to its compatible host. H group contains genotype 1 and genotype 2 HEV isolates which infect human only; Z group contains genotype 3 and genotype 4 HEV isolates which infect both human and animals. After analysis of amino acid sequences between ORF2 aa368 and aa606, four group-conserved sites that were all located in the neutralization region of ORF2 were identified. They are aa483, aa492, aa497 and aa599. Mutation analysis and capture PCR were then performed on these sites with a group of monoclonal antibodies. Results showed that the difference of the aa497 between H and Z groups was responsible for the maintenance of their group-specific immunodominant epitopes, probably through confirmation-dependent epitope changes. Thus, aa497 and its related change on the surface structure of HEV may play important roles in host selection by H and Z groups of HEV.
Antibodies, Monoclonal
;
immunology
;
Base Sequence
;
Genotype
;
Hepatitis E virus
;
classification
;
genetics
;
immunology
;
Humans
;
Immunodominant Epitopes
;
Molecular Sequence Data
;
Mutation
;
Neutralization Tests
;
Open Reading Frames
4.Evaluation of two anti-hepatitis E virus IgM kits.
Sheng-Xiang GE ; Ying-Jie ZHENG ; Qing-Shun GUO ; Jun ZHANG ; Qing-Wu JIANG ; Mun-Hon NG ; Ning-Shao XIA
Biomedical and Environmental Sciences 2007;20(6):512-515
OBJECTIVETo evaluate two commercial anti-hepatitis E virus (HEV) IgM kits used for differential diagnosis of acute enteric viral hepatitis.
METHODSThe kit for IgM capture assay, was produced with a recombinant HEV structural protein protecting primates against experimental infection by different HEV genotypes, while the other kit for indirect ELISA was produced with recombinant structural proteins from different HEV genotypes. The serum specimens were taken from 241 cases with a confirmed or presumptive diagnosis of hepatitis A and 74 cases with a confirmed or presumptive diagnosis of hepatitis E.
RESULTSThe sensitivity and specificity of the IgM capture assay kit were 97% and 100%, respectively, and the corresponding values for the other kit were 70% and 78%, respectively.
CONCLUSIONThe IgM capture assay kit has higher sensitivity and specificity in diagnosing acute enteric viral hepatitis E.
Diagnosis, Differential ; Hepatitis E ; diagnosis ; immunology ; Humans ; Immunoglobulin M ; blood ; immunology ; Reagent Kits, Diagnostic ; Sensitivity and Specificity
5.Expression of platelet collagen receptor-glycoprotein VI fragment in E. coli and its biological activities.
Zi-Qiang YU ; Ning-Zheng DONG ; Xia BAI ; Huai-Ping ZHU ; Shun-Dong JI ; Miao JIANG ; Chang-Geng RUAN
Journal of Experimental Hematology 2005;13(2):304-308
This study was aimed to further investigate the function of platelet collagen receptor-glycoprotein VI and to screen its specific inhibitor. The extracellular domain of platelet glycoprotein VI (GPVI) in E. coli was expressed by recombinant technology, the extracellular domain cDNA of GPVI was amplified from pBluescript KS(-)-GPVI plasmid by PCR. Proved by sequencing, the expression vector pET-20b(+)-GPVI was constructed, which was then transformed into E. coli (BL21(DE3)pLysS) and induced by IPTG. The recombinant GPVI was purified on Ni-NTA resin column and renatured in PBS containing GSH and GSSG. The anti-penta His McAb and anti-GPVI polyclonal antibody were used to identify the recombinant GPVI in Western blotting. Collagen binding test was conducted to investigate the biological activity of recombinant GPVI. The results showed that the recombinant GPVI was expressed in E. coli and successfully purified, which was confirmed to be similar to the native GPVI in Western blotting. The recombinant GPVI can bind the type I collagen in dose-dependent manner. In conclusion, the recombinant GPVI can be achieved in E. coli and restore its native characteristics after renaturation.
Blood Platelets
;
metabolism
;
Blotting, Western
;
Escherichia coli
;
genetics
;
Humans
;
Integrin alpha2beta1
;
Platelet Membrane Glycoproteins
;
biosynthesis
;
genetics
;
Protein Binding
;
Receptors, Collagen
;
biosynthesis
;
genetics
;
Recombinant Proteins
;
biosynthesis
;
isolation & purification
6.The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line.
Ying-yu CHEN ; Bao SHUANG ; Ya-xia TAN ; Min-jie MENG ; Pu HAN ; Xiao-ning MO ; Quan-sheng SONG ; Xiao-yan QIU ; Xin LUO ; Qi-ni GAN ; Xin ZHANG ; Ying ZHENG ; Shun-ai LIU ; Xiao-ning WANG ; Nan-shan ZHONG ; Da-long MA
Chinese Medical Journal 2005;118(4):267-274
BACKGROUNDThe genome of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) includes sequences encoding the putative protein X4 (ORF8, ORF7a), consisting of 122 amino acids. The deduced sequence contains a probable cleaved signal peptide sequence and a C-terminal transmembrane helix, indicating that protein X4 is likely to be a type I membrane protein. This study was conducted to demonstrate whether the protein X4 was expressed and its essential function in the process of SARS-CoV infection.
METHODSThe prokaryotic and eukaryotic protein X4-expressing plasmids were constructed. Recombinant soluble protein X4 was purified from E. coli using ion exchange chromatography, and the preparation was injected into chicken for rising specific polyclonal antibodies. The expression of protein X4 in SARS-CoV-infected Vero E6 cells and lung tissues from patients with SARS was performed using immunofluorescence assay and immunohistochemistry technique. The preliminary function of protein X4 was evaluated by treatment with and over-expression of protein X4 in cell lines. Western blot was employed to evaluate the expression of protein X4 in SARS-CoV particles.
RESULTSWe expressed and purified soluble recombinant protein X4 from E.coli, and generated specific antibodies against protein X4. Western blot proved that the protein X4 was not assembled in the SARS-CoV particles. Indirect immunofluorescence assays revealed that the expression of protein X4 was detected at 8 hours after infection in SARS-CoV-infected Vero E6 cells. It was also detected in the lung tissues from patients with SARS. Treatment with and overexpression of protein X4 inhibited the growth of Balb/c 3T3 cells as determined by cell counting and MTT assays.
CONCLUSIONThe results provide the evidence of protein X4 expression following SARS-CoV infection, and may facilitate further investigation of the immunopathological mechanism of SARS.
Amino Acid Sequence ; Animals ; BALB 3T3 Cells ; Cercopithecus aethiops ; Growth Inhibitors ; analysis ; physiology ; HeLa Cells ; Humans ; Immunohistochemistry ; Lung ; chemistry ; Mice ; Molecular Sequence Data ; SARS Virus ; chemistry ; Severe Acute Respiratory Syndrome ; metabolism ; Vero Cells ; Viral Structural Proteins ; analysis ; physiology
7.Multi-center clinical trial of FLAMIGEL (hydrogel dressing) for the treatment of residual burn wound.
Hui-zhong YANG ; Wen-kui WANG ; Li-li YUAN ; Shun-bin WANG ; Gao-xing LUO ; Jun WU ; Xi-hua NIU ; Bing-wei SUN ; Guang-gang DU ; Hai-hui LI ; Shun CHEN ; Zhao-hong CHEN ; Cheng-de XIA ; Shu-ren LI ; Tao LÜ ; Hui SUN ; Xi CHEN ; Xiao-long HE ; Bing ZHANG ; Jing-ning HUAN
Chinese Journal of Burns 2013;29(2):177-180
OBJECTIVETo evaluate the effect of FLAMIGEL (hydrogel dressing) on the repair of residual burn wound.
METHODSSixty burn patients with residual wounds hospitalized in 6 burn units from November 2011 to May 2012 were enrolled in the multi-center, randomized, and self-control clinical trial. Two residual wounds of each patient were divided into groups T (treated with FLAMIGEL) and C (treated with iodophor gauze) according to the random number table. On post treatment day (PTD) 7 and 14, wound healing rate was calculated, with the number of completely healed wound counted. The degree of pain patient felt during dressing change was evaluated using the visual analogue scale (VAS). The mean numbers of wounds with score equal to zero, more than zero and less than or equal to 3, more than 3 and less than or equal to 6, more than 6 and less than or equal to 10 were recorded respectively. Wound secretion or exudate samples were collected for bacterial culture, and the side effect was observed. Data were processed with repeated measure analysis of variance, t test, chi-square test, and nonparametric rank sum test.
RESULTSWound healing rate of groups T, C on PTD 7 was respectively (67 ± 24)%, (45 ± 25)%, and it was respectively (92 ± 16)%, (72 ± 23)% on PTD 14. There was statistically significant difference in wound healing rate on PTD 7, 14 between group T and group C (F = 32.388, P < 0.01). Ten wounds in group T and four wounds in group C were healed completely on PTD 7, with no significant difference between them (χ(2) = 0, P > 0.05). Forty-two wounds in group T and seven wounds in group C healed completely on PTD 14, with statistically significant difference between them (χ(2) = 42.254, P < 0.01). Patients in group T felt mild pain during dressing change for 37 wounds, with VAS score higher than zero and lower than or equal to 3. Evident pain was observed in patients of group C during dressing change for 43 wounds, and it scored higher than 3 and less than or equal to 6 by VAS evaluation. There was statistically significant difference in mean number of wounds with different grade of VAS score between group T and group C (Z = -4.638, P < 0.01). Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, E. coli, Baumanii, and Staphylococcus epidermidis were all detected in both groups, but there was no statistical difference between group T and group C (χ(2) = 0.051, P > 0.05). No side effect was observed in either of the two groups during the whole trial.
CONCLUSIONSFLAMIGEL can accelerate the healing of residual burn wounds and obviously relieve painful sensation during dressing change.
Adolescent ; Adult ; Aged ; Bandages ; Burns ; therapy ; Female ; Humans ; Hydrogels ; Male ; Middle Aged ; Young Adult
8.The preliminary analysis of the recognition epitopes of anti-HEV monoclonal antibodies on HEV ORF2.
Jun-Hui XIONG ; Qing-Shun GUO ; Sheng-Xiang GE ; Ying GU ; Yi-Xin CHEN ; Ji MIAO ; Hai-Lian DU ; Wei-Guo SHI ; Jun ZHANG ; Ning-Shao XIA
Chinese Journal of Virology 2008;24(2):83-87
Western blot, capture-PCR, blocking ELISA and synthetic polypeptides were used to systematically study the recognition epitopes on HEV ORF2 of 23 anti-HEV monoclonal antibodies(McAbs) which were previously generated in our laboratory directed against HEV ORF2. Results showed that seven McAbs recognized linear epitopes that located at aa408-458 of HEV ORF2 and 16 conformation-dependent McAbs, most of which recognized the surface epitopes of native HEV, located at aa459-606 of HEV ORF2. The systematical study of the recognition epitopes of anti-HEV McAbs on HEV ORF2 provides important information for the investigation of virus receptor and HEV infection mechanism, as well as its vaccine and diagnostics development.
Animals
;
Antibodies, Monoclonal
;
immunology
;
Enzyme-Linked Immunosorbent Assay
;
Epitopes
;
Hepatitis Antibodies
;
immunology
;
Hepatitis E virus
;
immunology
;
Mice
;
Mice, Inbred BALB C
;
Viral Proteins
;
immunology
9.Mouse strain-specific responses of mitochondrial respiratory function and cardiac hypertrophy to isoproterenol treatment.
Shuang-Ling LI ; Shun WANG ; Yuan HE ; Di ZHENG ; Jian LYU ; Ning-Ning GUO ; Ying-Ying GUO ; Li-Li LI ; Ming-Xia FAN ; Zhi-Hua WANG
Acta Physiologica Sinica 2021;73(3):459-470
Cardiac hypertrophy is a common pathological process of various cardiovascular diseases and eventually develops into heart failure. This paper was aimed to study the different pathological characteristics exhibited by different mouse strains after hypertrophy stimulation. Two mouse strains, A/J and FVB/nJ, were treated with isoproterenol (ISO) by osmotic pump to induce cardiac hypertrophy. Echocardiography was performed to monitor heart morphology and function. Mitochondria were isolated from hearts in each group, and oxidative phosphorylation function was assayed in vitro. The results showed that both strains showed a compensatory enhancement of heart contractile function after 1-week ISO treatment. The A/J mice, but not the FVB/nJ mice, developed significant cardiac hypertrophy after 3-week ISO treatment as evidenced by increases in left ventricular posterior wall thickness, heart weight/body weight ratio, cross sectional area of cardiomyocytes and cardiac hypertrophic markers. Interestingly, the heart from A/J mice contained higher mitochondrial DNA copy number compared with that from FVB/nJ mice. Functionally, the mitochondria from A/J mice displayed faster O
Animals
;
Cardiomegaly/chemically induced*
;
Heart Failure
;
Isoproterenol/toxicity*
;
Mice
;
Mitochondria
;
Myocytes, Cardiac/metabolism*
10.Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients.
Ying ZHENG ; Guang-Yan CAI ; Xiang-Mei CHEN ; Ping FU ; Jiang-Hua CHEN ; Xiao-Qiang DING ; Xue-Qing YU ; Hong-Li LIN ; Jian LIU ; Ru-Juan XIE ; Li-Ning WANG ; Zhao-Hui NI ; Fu-You LIU ; Ai-Ping YIN ; Chang-Ying XING ; Li WANG ; Wei SHI ; Jian-She LIU ; Ya-Ni HE ; Guo-Hua DING ; Wen-Ge LI ; Guang-Li WU ; Li-Ning MIAO ; Nan CHEN ; Zhen SU ; Chang-Lin MEI ; Jiu-Yang ZHAO ; Yong GU ; Yun-Kai BAI ; Hui-Min LUO ; Shan LIN ; Meng-Hua CHEN ; Li GONG ; Yi-Bin YANG ; Xiao-Ping YANG ; Ying LI ; Jian-Xin WAN ; Nian-Song WANG ; Hai-Ying LI ; Chun-Sheng XI ; Li HAO ; Yan XU ; Jing-Ai FANG ; Bi-Cheng LIU ; Rong-Shan LI ; Rong WANG ; Jing-Hong ZHANG ; Jian-Qin WANG ; Tan-Qi LOU ; Feng-Min SHAO ; Feng MEI ; Zhi-Hong LIU ; Wei-Jie YUAN ; Shi-Ren SUN ; Ling ZHANG ; Chun-Hua ZHOU ; Qin-Kai CHEN ; Shun-Lian JIA ; Zhi-Feng GONG ; Guang-Ju GUAN ; Tian XIA ; Liang-Bao ZHONG ; null
Chinese Medical Journal 2013;126(12):2276-2280
BACKGROUNDData on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease (CKD) patients are limited. The aim of the present study was to investigate the prevalence, awareness, treatment, and control of hypertension in the non-dialysis CKD patients through a nationwide, multicenter study in China.
METHODSThe survey was performed in 61 tertiary hospitals in 31 provinces, municipalities, and autonomous regions in China (except Hong Kong, Macao, and Taiwan). Trained physicians collected demographic and clinical data and measured blood pressure (BP) using a standardized protocol. Hypertension was defined as systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg, and/or use of antihypertensive medications. BP < 140/90 mmHg and < 130/80 mmHg were used as the 2 thresholds of hypertension control. In multivariate logistic regression with adjustment for sex and age, we analyzed the association between CKD stages and uncontrolled hypertension in non-dialysis CKD patients.
RESULTSThe analysis included 8927 non-dialysis CKD patients. The prevalence, awareness, and treatment of hypertension in non-dialysis CKD patients were 67.3%, 85.8%, and 81.0%, respectively. Of hypertensive CKD patients, 33.1% and 14.1% had controlled BP to < 140/90 mmHg and < 130/80 mmHg, respectively. With successive CKD stages, the prevalence of hypertension in non-dialysis CKD patients increased, but the control of hypertension decreased (P < 0.001). When the threshold of BP < 130/80 mmHg was considered, the risk of uncontrolled hypertension in CKD 2, 3a, 3b, 4, and 5 stages increased 1.3, 1.4, 1.4, 2.5, and 4.0 times compared with CKD 1 stage, respectively (P < 0.05). Using the threshold of < 140/90 mmHg, the risk of uncontrolled hypertension increased in advanced stages (P < 0.05).
CONCLUSIONSThe prevalence of hypertension Chinese non-dialysis CKD patients was high, and the hypertension control was suboptimal. With successive CKD stages, the risk of uncontrolled hypertension increased.
Adult ; Aged ; Awareness ; Female ; Humans ; Hypertension ; complications ; epidemiology ; therapy ; Male ; Middle Aged ; Prevalence ; Renal Insufficiency, Chronic ; complications